Aurobindo Pharma shares rise 0.16% as Nifty gains

Aurobindo Pharma shares rise 0.16% as Nifty gains
ETMarkets.com
Rate Story
Share
Font Size
Save
Comment
Synopsis

The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 620.55.

Shutterstock.com
RSI has turned north from the 60 level, confirming bullishness.
Shares of Ltd. traded 0.16 per cent up at Rs 723.75 on Wednesday at around 12:43PM (IST), while the benchmark BSE Sensex advanced 272.34 points to 60128.27.

As many as 52,191 shares changed hands on the counter with a total value of Rs 3.78 crore.

The stock quoted a 52-week high price of Rs 1063.75 and a 52-week low of Rs 620.55.

On the technical charts, the 200-DMA of the stock stood at Rs 829.62, while 50-DMA was at Rs 690.3. If a stock trades above 50 DMA and 200 DMA, it usually means the immediate trend is up. On the other hand, if the stock trades below 50 DMA and 200 DMA both, it is considered a bearish trend and if it trades between 50DMA and 200DMA, then it suggests the stock can go anywhere.

Shares of the company have advanced 26.04 per cent in the past one year, while Sensex has risen 32.01 per cent during the same period.

According to BSE data, the stock trades at a price-to-earnings multiple of 8.15 and a price-to-book ratio of 2.36. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price to book value indicates the inherent value of a company and reflects the price that investors are ready to pay even for no growth in a business. The stock belongs to the Pharma - Indian industry.

Pick the best companies to invest

BECOME AN ETPRIME MEMBER

Read More News on

(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

...more
Pick the best stocks for yourself
Powered by
Read before you invest. Insights on Aurobindo Pharma Ltd.. Explore Now